ArticleRheumatology (Oxford, England)2018

Minimal disease activity is a stable measure of therapeutic response in psoriatic arthritis patients receiving treatment with adalimumab.

Frank Behrens et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.